Abstract
In a novel preclinical model, primary amino bisphosphonates show greater potential for gastric effects than a pyridinyl bisphosphonate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/8756-3282(96)87944-0
Copy DOIPublication Date: Dec 1, 1995 |
In a novel preclinical model, primary amino bisphosphonates show greater potential for gastric effects than a pyridinyl bisphosphonate
Join us for a 30 min session where you can share your feedback and ask us any queries you have